Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia

Neurobiology of Disease(2022)10.1016/j.nbd.2022.105650Source: DataRank Database

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia is a research paper published in Neurobiology of Disease (2022). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 4.00)OA: goldTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Ellen J. Hess ORCID,David G. Standaert ORCID,Karen L. Eskow Jaunarajs ORCID,Mariangela Scarduzio ORCID

Live enrichment

PubMed:35139431 OpenAlex:https://openalex.org/W4210364572

US Department of Defense

Grant: PR191874

National Institutes of Health

Grant: NS108675

National Institutes of Health

Grant: R56NS124764

Parkinson's Disease Foundation Inc

American Parkinson Disease Association

Parkinson's Foundation

Dystonia Medical Research Foundation

FWCI

4.00

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S0969996122000419/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0969996122000419/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0969996122000419?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0969996122000419?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.nbd.2022.105650

Fields of Study

Neurological disorders and treatmentsGenetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments

MeSH Terms

Antiparkinson AgentsCorpus StriatumDystoniaHumansLevodopaDyskinesiasDystonic Disorders

Keywords

NeuroscienceNeurochemicalSynaptic plasticityDystoniaNeurotransmitterNeuromodulationDopamineAcetylcholinePsychologyPostsynaptic potentialEndocannabinoid systemDyskinesiaBiologyMedicinePharmacologyParkinson's diseaseCentral nervous systemInternal medicineDiseaseReceptorsNeurotransmittersStriatumBasal GangliaSynaptic DysfunctionL-dopa-induced Dyskinesia

Sustainable Development Goals

SDG 0: Good health and well-being